{"id":6638,"date":"2026-06-01T17:24:45","date_gmt":"2026-06-01T11:54:45","guid":{"rendered":"https:\/\/operonstrategist.com\/?p=6638"},"modified":"2026-06-01T17:24:45","modified_gmt":"2026-06-01T11:54:45","slug":"ce-drug-device-combination-ddcs","status":"publish","type":"post","link":"https:\/\/operonstrategist.com\/sa-en\/ce-drug-device-combination-ddcs\/","title":{"rendered":"Implementation of CE Drug-Device Combination Product (A Comprehensive Guide)"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-post\" data-elementor-id=\"6638\" class=\"elementor elementor-6638\" data-elementor-post-type=\"post\">\n\t\t\t\t<div class=\"elementor-element elementor-element-2cb5a3c8 e-flex e-con-boxed e-con e-parent\" data-id=\"2cb5a3c8\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-7c810b91 elementor-widget elementor-widget-heading\" data-id=\"7c810b91\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">Implementation of CE Drug-Device Combination Product (A Comprehensive Guide)<\/h2>\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-4acdd0d8 e-flex e-con-boxed e-con e-parent\" data-id=\"4acdd0d8\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t<div class=\"elementor-element elementor-element-672b862c e-con-full e-flex e-con e-child\" data-id=\"672b862c\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-7fe5f695 elementor-widget elementor-widget-text-editor\" data-id=\"7fe5f695\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<p>\u00a0<\/p><p><span style=\"font-weight: 400;\">Drug-device combinations (DDCs) are therapeutic and diagnostic items that mix medical devices, medicines, and\/or biological components. Because these are claimed to achieve medication targeting, they are regarded as safer and more effective treatments for local administration and personalized therapy. Such technologies are seen as beneficial to individuals suffering from major health conditions such as cancer, heart disease, multiple sclerosis, and diabetes, among others.\u00a0\u00a0<\/span><\/p><p><span style=\"font-weight: 400;\">Ex. Pre-filled syringe, Pen injector, Autoinjector, Metered dose inhaler, Drug-eluting stents, Catheter with antimicrobial coating, etc.<\/span><\/p><p><span style=\"font-weight: 400;\">The Operon Strategist is your key to easily navigating <\/span><a href=\"https:\/\/operonstrategist.com\/elevateplus\/us-fda-510k-qsmr-registration\/\"><span style=\"font-weight: 400;\">FDA510 (k)<\/span><\/a><span style=\"font-weight: 400;\">, MDA, MDR, and<\/span><a href=\"https:\/\/operonstrategist.com\/eu-regulations-for-marketing-medical-device-combination-products\/\"><span style=\"font-weight: 400;\"> EU regulations<\/span><\/a><span style=\"font-weight: 400;\">. Contact us for consultation.\u00a0<\/span><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-54c9456a e-con-full e-flex e-con e-child\" data-id=\"54c9456a\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t<div class=\"elementor-element elementor-element-7803d4e9 e-con-full e-flex e-con e-child\" data-id=\"7803d4e9\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-2dac43dc elementor-widget elementor-widget-heading\" data-id=\"2dac43dc\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t\t<h4 class=\"elementor-heading-title elementor-size-default\">Contact us for regulatory Guidance<\/h4>\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-56e25696 elementor-widget elementor-widget-wpforms\" data-id=\"56e25696\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"wpforms.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<div class=\"wpforms-container wpforms-container-full wpforms-render-modern\" id=\"wpforms-6203\"><form id=\"wpforms-form-6203\" class=\"wpforms-validate wpforms-form wpforms-ajax-form\" data-formid=\"6203\" method=\"post\" enctype=\"multipart\/form-data\" action=\"\/sa-en\/wp-json\/wp\/v2\/posts\/6638\" data-token=\"b052d33b46a99c46878b8e65cee993a9\" data-token-time=\"1780354534\"><noscript class=\"wpforms-error-noscript\">Please enable JavaScript in your browser to complete this form.<\/noscript><div id=\"wpforms-error-noscript\" style=\"display: none;\">Please enable JavaScript in your browser to complete this form.<\/div><div class=\"wpforms-field-container\">\t\t<div id=\"wpforms-6203-field_5-container\"\n\t\t\tclass=\"wpforms-field wpforms-field-text\"\n\t\t\tdata-field-type=\"text\"\n\t\t\tdata-field-id=\"5\"\n\t\t\t>\n\t\t\t<label class=\"wpforms-field-label\" for=\"wpforms-6203-field_5\" >Email Phone Name<\/label>\n\t\t\t<input type=\"text\" id=\"wpforms-6203-field_5\" class=\"wpforms-field-medium\" name=\"wpforms[fields][5]\" >\n\t\t<\/div>\n\t\t<div id=\"wpforms-6203-field_1-container\" class=\"wpforms-field wpforms-field-name\" data-field-id=\"1\"><label class=\"wpforms-field-label wpforms-label-hide\" for=\"wpforms-6203-field_1\" aria-hidden=\"false\">Name <span class=\"wpforms-required-label\" aria-hidden=\"true\">*<\/span><\/label><input type=\"text\" id=\"wpforms-6203-field_1\" class=\"wpforms-field-large wpforms-field-required\" name=\"wpforms[fields][1]\" placeholder=\"Name*\" aria-errormessage=\"wpforms-6203-field_1-error\" required><\/div><div id=\"wpforms-6203-field_2-container\" class=\"wpforms-field wpforms-field-email\" data-field-id=\"2\"><label class=\"wpforms-field-label wpforms-label-hide\" for=\"wpforms-6203-field_2\" aria-hidden=\"false\">Email <span class=\"wpforms-required-label\" aria-hidden=\"true\">*<\/span><\/label><input type=\"email\" id=\"wpforms-6203-field_2\" class=\"wpforms-field-large wpforms-field-required\" name=\"wpforms[fields][2]\" placeholder=\"Email*\" spellcheck=\"false\" aria-errormessage=\"wpforms-6203-field_2-error\" required><\/div><div id=\"wpforms-6203-field_3-container\" class=\"wpforms-field wpforms-field-phone\" data-field-id=\"3\"><label class=\"wpforms-field-label wpforms-label-hide\" for=\"wpforms-6203-field_3\" aria-hidden=\"false\">Phone <span class=\"wpforms-required-label\" aria-hidden=\"true\">*<\/span><\/label><input type=\"tel\" id=\"wpforms-6203-field_3\" class=\"wpforms-field-large wpforms-field-required wpforms-smart-phone-field\" data-rule-smart-phone-field=\"true\" name=\"wpforms[fields][3]\" placeholder=\"Phone*\" aria-label=\"Phone\" aria-errormessage=\"wpforms-6203-field_3-error\" required><\/div><div id=\"wpforms-6203-field_4-container\" class=\"wpforms-field wpforms-field-textarea\" data-field-id=\"4\"><label class=\"wpforms-field-label wpforms-label-hide\" for=\"wpforms-6203-field_4\" aria-hidden=\"false\">Paragraph Text <span class=\"wpforms-required-label\" aria-hidden=\"true\">*<\/span><\/label><textarea id=\"wpforms-6203-field_4\" class=\"wpforms-field-medium wpforms-field-required\" name=\"wpforms[fields][4]\" placeholder=\"Message\" aria-errormessage=\"wpforms-6203-field_4-error\" required><\/textarea><\/div><script>\n\t\t\t\t( function() {\n\t\t\t\t\tconst style = document.createElement( 'style' );\n\t\t\t\t\tstyle.appendChild( document.createTextNode( '#wpforms-6203-field_5-container { position: absolute !important; overflow: hidden !important; display: inline !important; height: 1px !important; width: 1px !important; z-index: -1000 !important; padding: 0 !important; } #wpforms-6203-field_5-container input { visibility: hidden; } #wpforms-conversational-form-page #wpforms-6203-field_5-container label { counter-increment: none; }' ) );\n\t\t\t\t\tdocument.head.appendChild( style );\n\t\t\t\t\tdocument.currentScript?.remove();\n\t\t\t\t} )();\n\t\t\t<\/script><\/div><!-- .wpforms-field-container --><div class=\"wpforms-submit-container\" ><input type=\"hidden\" name=\"wpforms[id]\" value=\"6203\"><input type=\"hidden\" name=\"page_title\" value=\"\"><input type=\"hidden\" name=\"page_url\" value=\"https:\/\/operonstrategist.com\/sa-en\/wp-json\/wp\/v2\/posts\/6638\"><input type=\"hidden\" name=\"url_referer\" value=\"\"><button type=\"submit\" name=\"wpforms[submit]\" id=\"wpforms-submit-6203\" class=\"wpforms-submit\" data-alt-text=\"Sending...\" data-submit-text=\"Submit\" aria-live=\"assertive\" value=\"wpforms-submit\">Submit<\/button><img decoding=\"async\" src=\"https:\/\/operonstrategist.com\/wp-content\/plugins\/wpforms\/assets\/images\/submit-spin.svg\" class=\"wpforms-submit-spinner\" style=\"display: none;\" width=\"26\" height=\"26\" alt=\"Loading\"><\/div><\/form><\/div>  <!-- .wpforms-container -->\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-6b23c16b e-flex e-con-boxed e-con e-parent\" data-id=\"6b23c16b\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-60aaef68 elementor-widget elementor-widget-text-editor\" data-id=\"60aaef68\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<p><span style=\"font-weight: 400;\">Drug-device combination products are emerging as a new dynamic in medical product development, regulatory approval, and business engagement, necessitating improved communication and collaboration. The development of new combination products and ensuring their timely and proper market access necessitates a specified system of interactions between manufacturers and regulatory bodies. <\/span><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-ce7924e elementor-widget elementor-widget-heading\" data-id=\"ce7924e\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">EU Regulation For Combination Medical Devices<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-db8ae08 elementor-widget elementor-widget-text-editor\" data-id=\"db8ae08\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<p><span style=\"font-weight: 400;\">The FDA specifically defines <\/span><a href=\"https:\/\/operonstrategist.com\/elevateplus\/drug-device-combination-product-documentation\/\"><span style=\"font-weight: 400;\">drug-device combination products<\/span><\/a><span style=\"font-weight: 400;\"> in 21 CFR 3.2(e), however, the EU does not have a single definition in its regulatory framework. The EU regulates combination items as either medicines or medical devices. The European Medicines Agency (EMA) assesses the medicinal product part of a combination device, whereas Notified Bodies assess the device part. Notified Bodies are organizations appointed by the EU Commission to evaluate the conformity of medical devices before they are placed on the market.\u00a0<\/span><\/p><p><span style=\"font-weight: 400;\">In response to numerous requests for advice on combination device quality requirements, the EMA provided \u201cDraft guidelines on quality requirements for medical devices in combination products,\u201d which addressed the new obligations in Regulation (EU) 2017\/745 on medical devices, specifically Article 117. This article requires that the marketing authorization application include a CE (Conformit\u00e9 Europ\u00e9enne) certificate or declaration of conformity for the device, or, in some situations, an opinion from a notified body (NB) on the item\u2019s conformity.<\/span><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-3d37526 elementor-widget elementor-widget-heading\" data-id=\"3d37526\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">Ema Guidelines For Drug-device Combination Products<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-f800123 elementor-widget elementor-widget-text-editor\" data-id=\"f800123\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<p><span style=\"font-weight: 400;\">This EMA recommendation applies to devices used for drug administration, dosage, and use. They may be integrated, co-packaged, or referenced in the drug\u2019s product information but obtained separately. It specifies which information about the device must be submitted as part of the original marketing authorization application and later over the product\u2019s lifecycle. It also includes a proposed template for the NB opinion on the device\u2019s conformance to the applicable standard safety and overall performance standards set out in Regulation (EU) 2017\/745. This guiding concept aims to enhance transparency and uniformity in regulatory filings, minimizing work for all stakeholders and ultimately improving impacted person protection.<\/span><\/p><p><strong>The Regulatory Framework For Medical Device Incorporating Medicinal Substances As An \u2018Integral Component\u2019 Is Described In Article 1(8) Of MDR:<\/strong><\/p><ul><li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Where the action of the medicinal substance is ancillary, the product is regulated as a medical device and ought to be CE marked. As the action of the medicinal product is considered ancillary, a systematic opinion needs to be provided from a medicines authority earlier than a notified body can issue a certificate for the combined product. Despite the fact that most of the people of digital developments are being driven and carried out inside the developed global, growing economies can be further left behind if they can not do development in regions so as to benefit them.<\/span><\/li><li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Where the action of the medicinal substance is main, the combination product is regulated under the medicinal products framework. In this situation, the relevant general safety and performance requirements (GSPR) of the <\/span><span style=\"font-weight: 400;\">MDR<\/span><span style=\"font-weight: 400;\"> apply to the device component.<\/span><\/li><\/ul>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-fbff885 elementor-widget elementor-widget-text-editor\" data-id=\"fbff885\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<p><strong>The regulatory framework For Administration Devices Is Described In Article 1(9) MDR:<\/strong><\/p><p><span style=\"font-weight: 400;\">\u201c(12) where a product is ruled by this directive, the marketing authorization dossier shall include, where available, the assessment of the evaluation of the conformity of the device element with the applicable general safety and overall performance requirements set out in annex i to that regulation contained inside the manufacturer\u2019s European announcement of conformity or the relevant certificate issued by way of a notified body allowing the manufacturer to hitch. If the dossier does not include the outcomes of the conformity evaluation cited inside the first subparagraph and where the conformity assessment of the device, if used separately, the involvement of a notified body is required in accordance with regulation (ECU) 2017\/745, the authority shall require the applicant to provide an opinion on the conformity of the tool part with the applicable general safety and overall performance requirements set out in annex i to that\u201d<\/span><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-d1bce8b elementor-widget elementor-widget-heading\" data-id=\"d1bce8b\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">Impact Of MPD(Medicinal Product Directive) On MAA (Marketing Authorization Application)<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-10065b7 elementor-widget elementor-widget-text-editor\" data-id=\"10065b7\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<p><span style=\"font-weight: 400;\">With the changes enforced using the EU MDR, the MAA should consist of either a:<\/span><\/p><ul><li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">CE certificates issued through a NB for the medical device component, or<\/span><\/li><\/ul><ul><li style=\"font-weight: 400;\" aria-level=\"1\"><a href=\"https:\/\/operonstrategist.com\/nb-opinions-for-ce-marking-and-us-fda-ddcp\/\"><span style=\"font-weight: 400;\">NBO (Notified body opinion) <\/span><\/a><span style=\"font-weight: 400;\">on the conformity of the device.<\/span><\/li><\/ul><p><span style=\"font-weight: 400;\">The first option would require medical device manufacturers to get CE marking through a product-specific conformity assessment method. The<\/span><span style=\"font-weight: 400;\"> CE certificate<\/span><span style=\"font-weight: 400;\"> would then need to be presented to the EMA via the MAA.<\/span><\/p><p><span style=\"font-weight: 400;\">Alternative option: If a <a href=\"https:\/\/operonstrategist.com\/elevateplus\/ce-marking-eu-mdr-ivdr\/\">CE mark<\/a> has not been awarded to the device component on its own, the maker must contact an NB and ask their opinion on the device\u2019s compliance, and then submit the NBO report in the MAA to EMA.\u00a0<\/span><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-e6347e4 elementor-widget elementor-widget-heading\" data-id=\"e6347e4\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">The Authority Of Final Approval Of The Product Will Remain With The EMA:\u200b\u200b<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-d659fe7 elementor-widget elementor-widget-text-editor\" data-id=\"d659fe7\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<p><span style=\"font-weight: 400;\">This regulatory change primarily affects combination devices that are integrated, non-reusable, and whose major mode of action is due to the medication element. Naturally, such devices are classed as Class Is [sterile], Class IIa, Class IIb, or Class III and meant only for the specified combination. These must comply with the Annex I (MDR) GSPR but are not required to be regulated as CE-medical devices. Combination devices classified as Class I (non-sterile) do not require an NB opinion.<\/span><\/p><p><strong>How Manufacturers can apply Article 117?\u00a0<\/strong><\/p><ul><li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Identify a NB intending to be EU MDR designated for your precise technology\u00a0<\/span><\/li><li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Investigate which GSPRs are applicable to your products<\/span><\/li><li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Obtain data that demonstrates conformance to the applicable GSPRs\u00a0<\/span><\/li><li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Assemble Technical Documents to aid the medical device components<\/span><\/li><\/ul><p><span style=\"font-weight: 400;\">One of the key challenges for drug-device combination devices are associated with addressing human factors studies and studies in representative user populations, particularly applicable to patient administered <\/span><span style=\"font-weight: 400;\">drug-device combinations<\/span><span style=\"font-weight: 400;\">. Important consideration needs to be given to the new requirements for post-market surveillance while preparing for operation.\u00a0<\/span><\/p><p><span style=\"font-weight: 400;\">Operon strategist closely worked with different regulatory agencies for more than a decade. We are <\/span><a href=\"https:\/\/operonstrategist.com\/services\/regulatory-approvals\/ce-marking\"><span style=\"font-weight: 400;\">CE mark medical device<\/span><\/a><span style=\"font-weight: 400;\"> certification consultants; we know how to classify the product and make a dossier as per classification which makes an error-free certification process. To avail our services do <\/span><a href=\"https:\/\/operonstrategist.com\/contact-us\/\"><span style=\"font-weight: 400;\">contact us<\/span><\/a><span style=\"font-weight: 400;\"> or <\/span><a href=\"https:\/\/api.whatsapp.com\/send\/?phone=919370283428&amp;text=Hi%2C+I+require+consultancy+for+medical+device.&amp;app_absent=0\" target=\"_blank\" rel=\"noopener\"><span style=\"font-weight: 400;\">whatsapp us<\/span><\/a><span style=\"font-weight: 400;\"> your requirement.<\/span><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>Drug-device combinations (DDCs) are therapeutic and diagnostic items that mix medical devices, medicines, and\/or biological components. Because these are claimed to achieve medication targeting, they are regarded as safer and more effective treatments for local administration and personalized therapy. Such technologies are seen as beneficial to individuals suffering from major health conditions such as cancer, [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":7081,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[55],"tags":[],"class_list":["post-6638","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-regulatory"],"_links":{"self":[{"href":"https:\/\/operonstrategist.com\/sa-en\/wp-json\/wp\/v2\/posts\/6638","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/operonstrategist.com\/sa-en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/operonstrategist.com\/sa-en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/operonstrategist.com\/sa-en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/operonstrategist.com\/sa-en\/wp-json\/wp\/v2\/comments?post=6638"}],"version-history":[{"count":0,"href":"https:\/\/operonstrategist.com\/sa-en\/wp-json\/wp\/v2\/posts\/6638\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/operonstrategist.com\/sa-en\/wp-json\/wp\/v2\/media\/7081"}],"wp:attachment":[{"href":"https:\/\/operonstrategist.com\/sa-en\/wp-json\/wp\/v2\/media?parent=6638"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/operonstrategist.com\/sa-en\/wp-json\/wp\/v2\/categories?post=6638"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/operonstrategist.com\/sa-en\/wp-json\/wp\/v2\/tags?post=6638"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}